Annual report pursuant to Section 13 and 15(d)

Statements of Changes in Stockholders' Deficit

v3.19.1
Statements of Changes in Stockholders' Deficit - USD ($)
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2016 $ 368 $ 1,598,982 $ (5,519,532) $ (3,920,182)
Balance, shares at Dec. 31, 2016 3,679,500      
Stock-based compensation expense 112,215 112,215
Stock-based compensation expense, shares      
Net loss (5,941,457) (5,941,457)
Balance at Dec. 31, 2017 $ 368 1,711,197 (11,460,989) (9,749,424)
Balance, shares at Dec. 31, 2017 3,679,500      
Stock-based compensation expense $ 1 557,041 557,042
Stock-based compensation expense, shares 8,334      
Stock issued in settlement of litigation 939,538 939,538
Conversion of Class B convertible preferred stock $ 137 4,961,431 4,961,568
Conversion of Class B convertible preferred stock, shares 1,366,768      
Issuance of warrants to third parties for capital raise 594,293 594,293
Conversion of deferred salaries $ 14 650,086 650,100
Conversion of deferred salaries, shares 136,863      
Conversion of convertible debentures $ 172 6,267,924 6,268,096
Conversion of convertible debentures, shares 1,726,678      
Conversion of advance from officer $ 4 199,996 200,000
Conversion of advance from officer, shares 42,105      
Conversion of notes payable $ 22 782,728 782,750
Conversion of notes payable, shares 215,625      
Sale of common stock in public offering $ 267 8,013,961 8,014,228
Sale of common stock in public offering, shares 2,670,000      
Sale of common stock in over-allotment to underwriters $ 2 121,907 121,909
Sale of common stock in over-allotment to underwriters, shares 25,000      
Common stock deemed dividend (980,375) (980,375)
Accretion of redeemable convertible preferred stock dividend (3,667,620) (3,667,620)
Net loss (27,651,412) (27,651,412)
Balance at Dec. 31, 2018 $ 987 $ 20,152,107 $ (39,112,401) $ (18,959,307)
Balance, shares at Dec. 31, 2018 9,870,873